A prospective study of serum tumour markers carcinoembryonic antigen, carbohydrate antigens 50 and 242, tissue polypeptide antigen and tissue polypeptide specific antigen in the diagnosis of pancreatic cancer with special reference to multivariate diagnostic score.
The aim of this study was to assess by a stepwise multivariate discriminant analysis the value of four current serum tumour markers - carcinoembryonic antigen (CEA), carbohydrate antigen (CA) 50 and CA 242 and tissue polypeptide antigen (TPA) - and a new serum tumour marker, tissue polypeptide speci...
Main Authors: | Pasanen, P. A., Eskelinen, M., Partanen, K., Pikkarainen, P., Penttilä, I., Alhava, E. |
---|---|
Format: | Online |
Language: | English |
Published: |
1994
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968866/ |
Similar Items
-
Independent prognostic value of preoperative serum markers CA 242, specific tissue polypeptide antigen and human chorionic gonadotrophin beta, but not of carcinoembryonic antigen or tissue polypeptide antigen in colorectal cancer.
by: Carpelan-Holmström, M., et al.
Published: (1996) -
Receiver operating characteristic (ROC) curve analysis of the tumour markers CEA, CA 50 and CA 242 in pancreatic cancer; results from a prospective study.
by: Pasanen, P. A., et al.
Published: (1993) -
Tissue polypeptide antigen (TPA) in pancreatic cancer diagnosis.
by: Panucci, A., et al.
Published: (1985) -
Clinical evaluation of a new serum tumour marker CA 242 in pancreatic carcinoma.
by: Pasanen, P. A., et al.
Published: (1992) -
Diagnostic value of tissue polypeptide-specific antigen (TPS) in neuroblastoma and Wilms' tumour.
by: Rebhandl, W., et al.
Published: (1998)